{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T04:07:40Z","timestamp":1759032460842,"version":"3.44.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007123","name":"Stanley Medical Research Institute","doi-asserted-by":"publisher","award":["13T-012"],"award-info":[{"award-number":["13T-012"]}],"id":[{"id":"10.13039\/100007123","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.jad.2022.07.020","type":"journal-article","created":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T11:32:30Z","timestamp":1658489550000},"page":"273-279","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The effect of adjunctive infliximab treatment on future cardiovascular disease risk in patients with bipolar disorder"],"prefix":"10.1016","volume":"316","author":[{"given":"Hartej","family":"Gill","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelson B.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo B.","family":"Mansur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9Ann A.","family":"Marks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua D.","family":"DiVincenzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felicia","family":"Ceban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua D.","family":"Rosenblat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan M.","family":"Lieberman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger S.","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2018","series-title":"Clinical Cases in Psychiatry: Integrating Translational Neuroscience Approaches","author":"Altamura","key":"10.1016\/j.jad.2022.07.020_bb0005"},{"key":"10.1016\/j.jad.2022.07.020_bb0010","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/360481","article-title":"Cytokines in bipolar disorder: paving the way for neuroprogression","volume":"2014","author":"Barbosa","year":"2014","journal-title":"Neural Plast."},{"key":"10.1016\/j.jad.2022.07.020_bb0015","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.psyneuen.2018.09.004","article-title":"Glucose and lipid-related biomarkers and the antidepressant response to infliximab in patients with treatment-resistant depression","volume":"98","author":"Bekhbat","year":"2018","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jad.2022.07.020_bb0020","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJMra035354","article-title":"Bipolar disorder","volume":"351","author":"Belmaker","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jad.2022.07.020_bb0025","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.neubiorev.2010.10.001","article-title":"Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors","volume":"35","author":"Berk","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jad.2022.07.020_bb0030","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4103\/hm.hm_24_19","article-title":"Inflammatory and vascular correlates of mood change over 8 weeks","volume":"3","author":"Birdsall","year":"2019","journal-title":"Heart Mind (Mumbai)"},{"key":"10.1016\/j.jad.2022.07.020_bb0035","doi-asserted-by":"crossref","first-page":"483","DOI":"10.7326\/0003-4819-151-7-200910060-00009","article-title":"C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. preventive services task force","volume":"151","author":"Buckley","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jad.2022.07.020_bb0040","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care","volume":"117","author":"D\u2019Agostino","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jad.2022.07.020_bb0045","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"D\u2019Agostino","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jad.2022.07.020_bb0050","series-title":"StatPearls","article-title":"Physiology, mean arterial pressure","author":"DeMers","year":"2021"},{"key":"10.1016\/j.jad.2022.07.020_bb0055","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1161\/CIRCULATIONAHA.107.759191","article-title":"Tumor necrosis factor-alpha and mortality in heart failure: a community study","volume":"118","author":"Dunlay","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jad.2022.07.020_bb0060","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0140-6736(09)61717-7","article-title":"C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis","volume":"375","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2022.07.020_bb0065","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/PSY.0b013e3181acee26","article-title":"Manic\/hypomanic symptom burden and cardiovascular mortality in bipolar disorder","volume":"71","author":"Fiedorowicz","year":"2009","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.jad.2022.07.020_bb0070","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1161\/CIRCULATIONAHA.108.797936","article-title":"Single versus combined blood pressure components and risk for cardiovascular disease: the Framingham Heart Study","volume":"119","author":"Franklin","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jad.2022.07.020_bb0075","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/sj.mp.4001793","article-title":"Treatment-resistant bipolar disorder","volume":"11","author":"Gitlin","year":"2006","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2022.07.020_bb0080","first-page":"1565","article-title":"Bipolar disorder and the vascular system: mechanisms and new prevention opportunities","volume":"33","author":"Goldstein","year":"2017","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.jad.2022.07.020_bb0085","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1399-5618.2009.00735.x","article-title":"Cardiovascular disease and hypertension among adults with bipolar I disorder in the United States","volume":"11","author":"Goldstein","year":"2009","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2022.07.020_bb0090","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1161\/CIR.0000000000000229","article-title":"Major depressive disorder and bipolar disorder predispose youth to accelerated atherosclerosis and early cardiovascular disease: a scientific statement from the American Heart Association","volume":"132","author":"Goldstein","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jad.2022.07.020_bb0095","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s11883-014-0435-z","article-title":"Inflammation and cardiovascular disease: from pathogenesis to therapeutic target","volume":"16","author":"Golia","year":"2014","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.jad.2022.07.020_bb0100","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jad.2022.07.020_bb0105","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/eurheartj\/eht462","article-title":"Depression and cardiovascular disease: a clinical review","volume":"35","author":"Hare","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jad.2022.07.020_bb0110","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.1365-2362.1998.00244.x","article-title":"Polymorphisms of the tumour necrosis factor-alpha gene, coronary heart disease and obesity","volume":"28","author":"Herrmann","year":"1998","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.jad.2022.07.020_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph15102073","article-title":"Factors associated with the risk of developing coronary artery disease in medicated patients with major depressive disorder","volume":"15","author":"Ho","year":"2018","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.jad.2022.07.020_bb0120","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","article-title":"Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis","volume":"71","author":"Howren","year":"2009","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.jad.2022.07.020_bb0125","first-page":"1213","article-title":"Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis","volume":"32","author":"Jacobsson","year":"2005","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jad.2022.07.020_bb0130","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s41043-017-0114-0","article-title":"Framingham risk score for estimation of 10-years of cardiovascular diseases risk in patients with metabolic syndrome","volume":"36","author":"Jahangiry","year":"2017","journal-title":"J. Health Popul. Nutr."},{"key":"10.1016\/j.jad.2022.07.020_bb0135","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jad.2015.03.027","article-title":"Causes of decreased life expectancy over the life span in bipolar disorder","volume":"180","author":"Kessing","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2022.07.020_bb0140","doi-asserted-by":"crossref","first-page":"645","DOI":"10.2165\/00003088-200746080-00002","article-title":"Clinical pharmacokinetics and use of infliximab","volume":"46","author":"Klotz","year":"2007","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jad.2022.07.020_bb0145","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.cardiores.2004.12.026","article-title":"Inflammatory markers and cardiovascular health in older adults","volume":"66","author":"Kritchevsky","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.jad.2022.07.020_bb0150","doi-asserted-by":"crossref","first-page":"54","DOI":"10.15324\/kjcls.2016.48.2.54","article-title":"The assessment of Framingham risk score and 10 year CHD risk according to application of LDL cholesterol or total cholesterol","volume":"48","author":"Kwon","year":"2016","journal-title":"Korean J.Clin. Lab. Sci."},{"key":"10.1016\/j.jad.2022.07.020_bb0155","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.bbi.2020.04.063","article-title":"Efficacy of adjunctive infliximab vs. placebo in the treatment of anhedonia in bipolar I\/II depression","volume":"88","author":"Lee","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jad.2022.07.020_bb0160","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.amjcard.2004.03.023","article-title":"Framingham risk score and prediction of lifetime risk for coronary heart disease","volume":"94","author":"Lloyd-Jones","year":"2004","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.jad.2022.07.020_bb0165","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1016\/j.ijcard.2012.07.018","article-title":"Cardiovascular risk prediction in the general population with use of suPAR, CRP, and Framingham Risk Score","volume":"167","author":"Lyngb\u00e6k","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.jad.2022.07.020_bb0170","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.pnpbp.2017.07.026","article-title":"C-reactive protein and cardiovascular risk in bipolar disorder patients: a systematic review","volume":"79","author":"Marshe","year":"2017","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2022.07.020_bb0175","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1001\/jamapsychiatry.2019.0779","article-title":"Efficacy of adjunctive infliximab vs placebo in the treatment of adults with bipolar I\/II depression: a randomized clinical trial","volume":"76","author":"McIntyre","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2022.07.020_bb0180","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/S0140-6736(20)31544-0","article-title":"Bipolar disorders","volume":"396","author":"McIntyre","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2022.07.020_bb0185","first-page":"913","article-title":"Canadian Cardiovascular Society position statement \u2013 recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease","volume":"22","author":"McPherson","year":"2006","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.jad.2022.07.020_bb0190","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1001\/archpsyc.64.5.543","article-title":"Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication","volume":"64","author":"Merikangas","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2022.07.020_bb0195","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.biopsych.2013.01.007","article-title":"Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies","volume":"74","author":"Modabbernia","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2022.07.020_bb0200","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jpsychires.2013.05.018","article-title":"Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis","volume":"47","author":"Munkholm","year":"2013","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2022.07.020_bb0205","doi-asserted-by":"crossref","first-page":"784","DOI":"10.5551\/jat.19356","article-title":"Predicting coronary heart disease using risk factor categories for a Japanese urban population, and comparison with the Framingham risk score: the Suita study","volume":"21","author":"Nishimura","year":"2014","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.jad.2022.07.020_bb0210","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.numecd.2009.07.005","article-title":"Lipids, atherosclerosis and CVD risk: is CRP an innocent bystander?","volume":"19","author":"Nordestgaard","year":"2009","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.jad.2022.07.020_bb0215","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/archpsyc.58.9.844","article-title":"Excess mortality in bipolar and unipolar disorder in Sweden","volume":"58","author":"\u00d6sby","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2022.07.020_bb0220","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","article-title":"A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers","volume":"70","author":"Raison","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2022.07.020_bb0225","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1161\/01.CIR.0000125690.80303.A8","article-title":"Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham risk scores","volume":"109","author":"Ridker","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jad.2022.07.020_bb0230","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pnpbp.2014.01.013","article-title":"Inflamed moods: a review of the interactions between inflammation and mood disorders","volume":"53","author":"Rosenblat","year":"2014","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2022.07.020_bb0235","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/bdi.12373","article-title":"Anti-inflammatory agents in the treatment of bipolar depression: a systematic review and meta-analysis","volume":"18","author":"Rosenblat","year":"2016","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2022.07.020_bb0240","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1159\/000228249","article-title":"Functioning and disability in bipolar disorder: an extensive review","volume":"78","author":"Sanchez-Moreno","year":"2009","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.jad.2022.07.020_bb0245","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1161\/01.HYP.36.5.801","article-title":"Systolic and diastolic blood pressure, pulse pressure, and mean arterial pressure as predictors of cardiovascular disease risk in men","volume":"36","author":"Sesso","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.jad.2022.07.020_bb0250","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/acr.23875","article-title":"Comparative risk of cardiovascular events with biologic and synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a systematic review and meta-analysis","volume":"72","author":"Singh","year":"2020","journal-title":"Arthritis CareRes."},{"key":"10.1016\/j.jad.2022.07.020_bb0255","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.neuro.2009.03.004","article-title":"The effect of tumor necrosis factor antagonists on mood and mental health-associated quality of life: novel hypothesis-driven treatments for bipolar depression?","volume":"30","author":"Soczynska","year":"2009","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.jad.2022.07.020_bb0260","doi-asserted-by":"crossref","first-page":"246","DOI":"10.4162\/nrp.2012.6.3.246","article-title":"The Framingham risk score, diet, and inflammatory markers in Korean men with metabolic syndrome","volume":"6","author":"Sohn","year":"2012","journal-title":"Nutr. Res. Pract."},{"key":"10.1016\/j.jad.2022.07.020_bb0265","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/jch.13855","article-title":"Validating the Framingham hypertension risk score: a 4-year follow-up from the Brazilian Longitudinal Study of the Adult Health (ELSA-Brasil)","volume":"22","author":"Syllos","year":"2020","journal-title":"J. Clin. Hypertens."},{"key":"10.1016\/j.jad.2022.07.020_bb0270","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nature05487","article-title":"Mechanisms linking obesity with cardiovascular disease","volume":"444","author":"Van Gaal","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jad.2022.07.020_bb0275","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/jhh.2013.80","article-title":"Infliximab, a TNF-\u03b1 inhibitor, reduces 24-h ambulatory blood pressure in rheumatoid arthritis patients","volume":"28","author":"Yoshida","year":"2014","journal-title":"J. Hum. Hypertens."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032722007881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032722007881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T03:27:17Z","timestamp":1759030037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032722007881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":55,"alternative-id":["S0165032722007881"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2022.07.020","relation":{},"ISSN":["0165-0327"],"issn-type":[{"type":"print","value":"0165-0327"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of adjunctive infliximab treatment on future cardiovascular disease risk in patients with bipolar disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2022.07.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}